A chemical compound may be easy to find online and still be unavailable for an actual research or development project. A chemical name, structure, CAS Registry Number, database record and supplier page each establish different facts. None of them alone proves that the required product can be delivered in the correct form, quantity, timeframe and quality.

For scientists, project managers and procurement teams, the useful question is therefore not simply “Does this compound exist?” It is: “Can we obtain a material that is documented, application-ready and available when we need it?” This guide provides a practical framework for answering that question.

Quick answer: A chemical compound should be considered commercially available for a specific project only when the correct chemical form can actually be supplied in the required quantity and timeframe, with a specification and analytical evidence that support its intended use. A catalogue entry or CAS Registry Number alone does not establish this.

---

Key Takeaways

• Chemical identity, catalogue listing, physical stock and application suitability are separate questions.
• A CAS Registry Number identifies a substance; it does not confirm inventory, lead time or usable quality.
• Nominal purity is meaningful only together with the analytical method and the relevant impurity profile.
• Commercial availability must be checked for the required chemical form, quantity, timeframe, documentation and application.
• Re-analysis or purification may be sufficient when a suitable material exists but is incompletely documented.
• Custom synthesis becomes relevant when no available product meets the required identity, specification, amount or continuity of supply.

---

Contents

• What does commercially available mean?
• Why does a CAS Registry Number not prove availability?
• How can commercial availability be verified?
• Why is specification more important than purity alone?
• Which sourcing response fits which situation?
• When is custom synthesis required?
• What information should be defined?
• How can a chemical CRO help?
• Frequently asked questions

---

What Does “Commercially Available” Mean in Practice?

Commercial availability is not a single binary property of a molecule. It describes whether a defined chemical product can be obtained under conditions that make it usable for a particular project.

A compound can move through several levels of availability:

Level	What is established?	What remains uncertain?
Identified	A name, structure or chemical identifier is available.	Whether any supplier offers the substance.
Listed	The compound appears in a catalogue or marketplace.	Actual stock, quantity, lead time and lot-specific quality.
Deliverable	A supplier confirms that a defined amount can be shipped.	Whether the supplied grade is suitable for the intended application.
Application-ready	The identity, form, specification and analytical evidence meet the project requirements.	Whether equivalent material will be available again.
Repeatably available	A reproducible route, quality-control approach and supply plan support future batches.	Changes in raw materials, process or agreed requirements still require control.

This distinction matters because a procurement search is often performed at the level of chemical identity, while the experiment or product development programme depends on the properties of an actual batch.

Why Does a CAS Registry Number Not Prove Commercial Availability?

A CAS Registry Number is an identifier, not a statement about stock or market supply. CAS explains that each CAS Registry Number uniquely identifies one substance in CAS REGISTRY. Substances can enter the registry through disclosed scientific literature or through a request for registration. The identifier therefore helps establish which substance is being discussed, but it does not mean that a product is manufactured, stocked or sold in a particular grade.

This is especially important when a project requires a specific:

• salt, counterion, hydrate or solvate;
• stereoisomer, regioisomer or isotopologue;
• particle form, polymorph or physical state;
• impurity profile or residual-solvent limit;
• analytical documentation package;
• quantity or recurring batch supply.

Search tools can help identify possible sources. For example, the Physical Sciences Data Infrastructure describes its Chemical Availability Search as a way to compare supplier and pricing information and provides an option to filter for products reported as in stock. Even then, a project-specific check remains necessary because database information cannot replace confirmation of the current lot, specification and delivery commitment.

How Can the Commercial Availability of a Chemical Compound Be Verified?

A robust availability check should test seven separate criteria: identity, supply status, quantity, specification, analytical evidence, application fit and continuity.

Question	Evidence to request or review
1. Is it the correct chemical identity?	Structure, chemical name, identifier, molecular formula, stereochemistry and required salt or solvate form.
2. Is material actually available?	Written stock confirmation, lot number, manufacturing status or a binding quotation.
3. Can the required quantity be delivered on time?	Confirmed amount, pack size, lead time, shipping conditions and shelf-life information.
4. Does the specification cover the relevant attributes?	Acceptance limits for identity, purity, assay, water, residual solvents, inorganic content and any application-specific parameters.
5. Are the analytical methods defined and suitable?	Method descriptions, detector conditions, reference standards, chromatograms, spectra or other lot-specific data.
6. Is the material fit for the intended use?	An application-based assessment of critical impurities, biological or physical attributes, matrix compatibility and handling requirements.
7. Can equivalent quality be supplied again?	Information on manufacturing route, batch consistency, change control, raw-material availability and repeat-supply capability.

The required depth of verification depends on the application. An exploratory screening experiment, a quantitative LC–MS/MS method, an electronic material and a pharmaceutical development programme do not need the same evidence. “Fit for purpose” must therefore be translated into measurable attributes before suppliers are compared.

Why Is the Specification More Important Than Purity Alone?

A purity value cannot establish suitability unless the analytical basis of that value and the identity of relevant impurities are known.

For example, “98% purity by HPLC area” normally describes the relative areas of detected chromatographic peaks under one defined method. It does not automatically quantify water, inorganic salts, non-detected compounds or every component with a different detector response. A value obtained by quantitative NMR, assay against a reference standard or mass balance answers a different analytical question.

A useful chemical specification may therefore include:

• identity and chemical form;
• assay or purity with the stated analytical method;
• specified and unspecified organic impurities;
• water content and residual solvents;
• inorganic or elemental impurities where relevant;
• stereochemical or isotopic composition;
• physical properties such as solid form, particle size or solubility;
• microbiological attributes or endotoxin limits when required by the application;
• storage conditions, stability or retest period;
• the expected certificate and supporting analytical data.

In the pharmaceutical context, ICH Q6A describes a specification as a list of tests, references to analytical procedures and acceptance criteria. Q6A is written for new drug substances and products and is not a universal requirement for all research or industrial chemicals. Its structure nevertheless illustrates an important general principle: a limit without a defined test method is incomplete.

The specification also affects technical effort and price. Requiring a higher nominal purity or a tighter impurity limit can change purification, yield, analytical workload and cost. This relationship is examined separately in Chemical Custom Synthesis Costs Explained.

Which Sourcing Response Fits Which Availability Problem?

Not every availability gap requires a complete new synthesis. The appropriate response depends on whether the gap concerns evidence, quality, chemical form, quantity or the absence of any viable source.

Situation	Proportionate response
A current lot is available and meets the complete application-specific specification.	Purchase the catalogue material and retain the agreed lot documentation.
The material is listed, but stock or lead time is uncertain.	Request written confirmation, a formal quotation and lot-specific information.
The correct material appears to exist, but the certificate is incomplete.	Obtain a sample and perform targeted re-analysis before commissioning new synthesis.
The correct identity is available, but the impurity profile or grade is unsuitable.	Evaluate purification, form conversion or a synthesis route designed for the required quality.
A known compound is unavailable in the required amount or cannot be supplied repeatedly.	Establish a reproducible custom-synthesis and quality-control route.
The target is novel or no workable route is available.	Plan first-time synthesis, route scouting and staged feasibility work.

This staged approach prevents two opposite errors: commissioning an unnecessary synthesis when verification or purification would solve the problem, and purchasing a nominally available product that cannot support the intended work.

When Is Custom Synthesis Required for a Known Compound?

Custom synthesis is appropriate when the chemical identity is known but no available product meets the project’s required form, quality, quantity, documentation or supply continuity.

A known compound can therefore be commercially unavailable for the required application even when a database record or supplier page exists. Typical reasons include:

• the offered salt, stereoisomer or isotopic form is incorrect;
• critical impurities are uncontrolled;
• the catalogue quantity is too small or no current lot exists;
• the analytical documentation is insufficient;
• the material must be produced repeatedly with comparable quality;
• the existing preparation is uneconomic, unsafe or unsuitable for scale-up.

This situation is different from the first synthesis of a completely novel molecule. Both can require chemical custom synthesis, but the starting information, project risks and development strategy are not the same. The broader distinction is discussed in Custom-Synthesized Molecules.

Analytical standards provide a useful example. A labelled reference compound may be listed, while the required isotope, label position, enrichment, chemical purity or documentation is missing. See What Are Stable-Isotope-Labelled Reference Compounds and When Is Custom Synthesis Required?.

What Information Should Be Defined Before Contacting a Supplier or CRO?

The enquiry should describe the required product and its intended function, not only the molecular name and a purity percentage.

A useful request contains:

1. Target identity: structure, name, identifier and required stereochemistry, salt, solvate or isotopic form.
2. Intended use: research, analytical, diagnostic, material, process-development or other application.
3. Quantity: initial amount and realistic expectations for later batches.
4. Specification: required limits, relevant impurities and physical attributes.
5. Analytical scope: required methods, raw data, certificate format and reference standards.
6. Timing: target delivery date and any staged material needs.
7. Supply model: one-off preparation or recurring supply.
8. Existing knowledge: literature routes, internal results, reference samples and known technical problems.

These details allow a supplier to distinguish a simple sourcing task from re-analysis, purification, route development or a full custom-synthesis project. They also make quotations more comparable.

How Can a Chemical CRO Make a Known Compound Practically Available?

A chemical CRO can close the gap between a known molecular identity and a reproducibly supplied, application-ready material.

Depending on the project, this may involve:

1. checking genuine market supply and evaluating existing grades;
2. translating the intended use into critical quality attributes;
3. identifying gaps in certificates and analytical methods;
4. re-analysing, purifying or converting an existing material;
5. developing or adapting a synthesis route;
6. defining release tests and acceptance limits;
7. establishing reproducible future batches and a suitable supply strategy.

When later quantities are likely to increase, route robustness and scale should be considered early. The changing requirements from discovery quantities to process development and manufacturing are explained in Chemical Custom Synthesis Across Development Stages.

One practical example of this provider role is ChiroBlock GmbH, a German specialist in chemical custom synthesis, route scouting and the production of complex, non-commercially available molecules from milligram to kilogram scale. Its corporate knowledge cluster describes the pathway from a known compound to customer-specific quality and reliable recurring supply.

Practical Decision Rule

Treat a compound as commercially available for your project only when a supplier can provide the correct material, in the required amount and timeframe, with suitable analytical evidence and a specification that addresses the intended use.

If any of these conditions is missing, identify the exact gap before deciding between a different catalogue source, re-analysis, purification, form conversion or custom synthesis.

Conclusion

A chemical compound is not practically available merely because it can be found in a database or supplier catalogue. Real availability is product- and application-specific. It combines correct identity, actual supply, sufficient quantity, defined quality, suitable analytical methods and, where necessary, reproducible future batches.

This perspective helps R&D and procurement teams avoid unsuitable purchases, incomplete specifications and unnecessary synthesis projects. It also creates a clearer basis for comparing suppliers and planning chemical custom synthesis when the market cannot provide the required material.

For a personal chemical-CRO perspective on the same underlying problem, read Dr Oliver Seidelmann’s article Is a Chemical Compound Commercially Available or Not?

Frequently Asked Questions

Does a CAS Registry Number mean that a compound can be purchased?

No. A CAS Registry Number uniquely identifies a registered substance. It does not confirm that a supplier currently manufactures or stocks the substance, or that it is available in the required grade and quantity.

Can two products with the same chemical identity perform differently?

Yes. Products with the same nominal identity can differ in assay, impurity profile, water content, residual solvents, solid form, particle properties and analytical documentation. These differences may affect an experiment or manufacturing process.

Is a supplier catalogue entry reliable evidence of current stock?

A catalogue entry is useful evidence that a supplier has offered the material, but current availability should be confirmed through lot information, a quotation or written stock and lead-time confirmation.

Does 99% purity mean the same thing for every supplier?

No. The result depends on the method, detector, calculation and components covered by the analysis. A chromatographic area percentage, quantitative assay and mass-balance value are not automatically equivalent.

What is the difference between commercial availability and availability to specification?

Commercial availability means that some form of a product can be obtained. Availability to specification means that the actual material meets defined identity, quality, analytical and application requirements.

When is re-analysis sufficient?

Re-analysis may be sufficient when an existing batch is likely to be suitable but the supplier’s documentation does not cover a critical parameter. The sample must be representative, and the additional analytical method must be appropriate for the intended decision.

When is purification preferable to a new synthesis?

Purification may be preferable when enough of the correct chemical form is available and the unwanted components can be removed without unacceptable loss, degradation or cost. A feasibility assessment should compare purification with a revised synthesis route.

When is custom synthesis required for a known compound?

Custom synthesis may be required when no supplier can provide the required chemical form, impurity profile, quantity, documentation or repeatability, even though the compound itself is already known.

How should recurring supply be assessed?

Recurring supply requires more than one acceptable lot. The synthesis or sourcing route, raw-material availability, process controls, release methods, batch documentation and management of changes should support consistent future batches.

Sources and Scope

• CAS REGISTRY – role and meaning of CAS Registry Numbers as substance identifiers.
• Physical Sciences Data Infrastructure: Searching Chemical Availability (ChASe) – supplier and availability search context.
• ICH Quality Guidelines: Q6A – pharmaceutical definition of specifications, test procedures and acceptance criteria.

Scope note: The verification framework in this article is general decision guidance for chemical sourcing and custom-synthesis planning. Application-specific regulatory, quality or safety requirements must be assessed separately.

---

Editorial Information

Written by: ChiroBlock GmbH Editorial Team

Expert perspective: Dr Oliver Seidelmann, Chemist, Managing Director and Co-Founder of ChiroBlock GmbH

Last reviewed: 26 August 2026

Sources reviewed: CAS, Physical Sciences Data Infrastructure, ICH and related technical articles listed above

Update policy: Review when relevant availability databases, analytical guidance or the linked provider information changes materially.

---

From Availability Check to a Defined Supply Route

If a known compound is listed but cannot be obtained in the required specification, quantity or repeatable quality, review the chemical custom synthesis services provided by ChiroBlock. For a specific and confidential project assessment, use the verified ChiroBlock project contact.

• Chemical Custom Synthesis
• Chemical Custom Synthesis Blog
• Uncategorized

#4Synth #ChemicalNetwork #ChiroBlock #CustomSynthesis Analytical Characterisation Analytical Standards Chemical Availability Chemical Biology Chemical Custom Synthesis Chemical Sourcing Chemical Specification Custom Synthesis Internal Standards LC-MS/MS New World Screwworm Non-Commercially Available Compounds Parasite Research Reference Compounds Research Compounds Stable Isotopes

• Why Can a 99% Pure Chemical Still Fail in Production?
• How to Transfer a Chemical Synthesis Process to GMP Manufacturing
• How to Verify the Commercial Availability of a Chemical Compound
• What Are Stable-Isotope-Labelled Reference Compounds and When Is Custom Synthesis Required?
• How Custom Chemical Synthesis Supports Parasite Research